Introduction {#S1}
============

Solid organ transplantation is becoming increasingly common in the treatment of end-stage organ failure. The two crucial factors for successful organ transplantation are: i) better control of rejection by administration of immunosuppressant therapy, and ii) better prevention and treatment of infection which transplant patients are more predisposed to, on account of the immunosuppression-induced compromised cell-mediated immunity. Up to 15% of renal transplant recipients die of opportunistic infections.^[@R1]^ Infections are most common during the first 6 months post-transplant.^[@R2],[@R3]^ Infections may be exogenous in origin due to environmental exposure to infective agents, or they may occur as a result of invasion by endogenous opportunistic agents (bacteria, viruses or fungi). We report two opportunistic infections, namely, primary cutaneous aspergillosis and intestinal tuberculosis, with terminal enterococcal pleuritis and peritonitis, in a renal transplant recipient.

Case Report {#S2}
===========

A 30 year old male patient who was a case of chronic glomerulonephritis and had developed end-stage renal disease, had received a renal transplant 10 months back. He was on immunosuppressant therapy (tacrolimus 4 mg/day, mycophenolate mofetyl 1.5 gm/day and steroid prednisolone 7.5 mg/day). He presented with a 6-month history of a mass in the right sole, discharging pus. Prior to this, he had a long-standing wound of 2 months duration at the same location, close to the heel, which he attributed to pressure from his shoe. The wound was not present prior to the transplantation. On examination, the mass was tender, firm, indurated, 4×5 cm in size, situated subcutaneously. The overlying skin was dark brown. His haematological and biochemical parameters were normal.

The mass was excised along with the overlying elliptical part of skin and the deeper subcutaneous tissue. Macroscopic examination of the excised specimen showed multiple sinuses 0.2 to 0.4 cm in size on the skin surface, draining whitish pus. The cut surface showed necrotic material. On microscopic examination, ulcerated skin was seen. In the keratin layer of the epidermis, and in the dermis, there were numerous fungal hyphae which appeared dark brown, septate, and showed acute-angle branching ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). The fungus was surrounded by neutrophilic microabscesses. Dense inflammatory cell infiltrates were extending up to the subcutaneous fat. Fungal culture from the tissue isolated *Aspergillus niger.* A thorough search did not reveal any focus of *Aspergillus* infection anywhere else in the body. The patient tested seronegative for human immunodeficiency virus (HIV) infection. He was started on antifungal therapy, viz. oral voriconazole 200 mg/day. The dosage of immunosuppressant tacrolimus was reduced.

Figure 1Photomicrograph showing dark brown, septate fungal hyphae with acuteangle branching (Haematoxylin and Eosin x 1000).

Figure 2Photomicrograph showing fungal hyphae in the keratin layer of the epidermis, highlighted by periodic acid Schiff staining (magenta colour) (Periodic acid Schiff x 400).

One month later, during a follow-up visit for his renal status, the patient showed signs of graft dysfunction, his serum creatinine being 2.5 mg/dL (normal range 0.6--1.2 mg/dL). A renal biopsy was done. It showed normal glomeruli and blood vessels. There was evidence of mild tubulitis (1--4 mononuclear cells/tubular cross section). The interstitium showed oedema and a moderate degree of inflammation with infiltration by mainly lymphocytes admixed with macrophages, affecting about 10% of the parenchyma. The findings were categorized as borderline changes, suspicious of acute rejection (Banff classification 2007^[@R4]^). This necessitated anti-rejection therapy with pulse dose methylprednisolone intravenously for 3 days, followed by oral prednisolone. The patient discontinued the anti-fungal therapy on his own. He did not visit the concerned clinician for follow-up, and hence a repeat fungal culture or biopsy from the surgical site was not done.

Six weeks later, the patient complained of pain in abdomen of 5 days duration, and vomiting since 2 days. He was diagnosed to have peritonitis secondary to hollow viscus (ileal) perforation. A haemogram done revealed haemoglobin 7.0 gm/dL (normal range 13.0--18.0 gm/dL), haematocrit 20.4% (normal range 40--54%), total leukocyte count 10,400 cells/µL with 74% neutrophils and 22% lymphocytes (normal range 4,000--11,000 cells/µL with 40--75% neutrophils and 20--50% lymphocytes), and platelet count 85,000 cells/µL (normal range 1,50,000--4,00,000 cells/µL). The patient underwent laparotomy. A segment of perforated ileum was resected and subjected to histopathological examination. Grossly, the segment of ileum measured 7 cm in length. It showed a central perforation measuring 1 cm in diameter, surrounded by shaggy mucosa. Microscopically, the intestinal mucosa showed large areas of ulceration ([Figure 3](#F3){ref-type="fig"}A). There was dense transmural infiltration by neutrophils and lymphocytes ([Figures 3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B). An occasional ill-formed epithelioid granuloma was seen. Staining for acid fast bacilli revealed strong positivity, confirming the presence of *Mycobacterium tuberculosis* ([Figure 4](#F4){ref-type="fig"}). A diagnosis of ileal tuberculosis with perforation, was made.

Figure 3A) Photomicrograph showing ulcerated intestinal mucosa with dense inflammatory cell infiltration (Haematoxylin and Eosin x 100); B) dense infiltration by neutrophils and lymphocytes, in the intestinal wall (Haematoxylin and Eosin x 400).

Figure 4Photomicrograph showing strong positivity for acid fast bacilli (Ziehl-Neelsen stain x 1000).

Further investigation by sputum smear staining revealed acid fast bacilli, indicating that the patient also had pulmonary tuberculosis. He had pleural effusion and mild ascites. Culture of the pleural and peritoneal fluids revealed enterococcus; hence enterococcal pleuritis and peritonitis was diagnosed. The patient was started on antituberculous *RIPE therapy* (with rifampicin 600 mg/day, isoniazid 300 mg/day, pyrazinamide 1500 mg/day and ethambutol 1500 mg/day), along with intravenous antibiotics. However, six days later, he developed signs of septic shock and expired.

Discussion {#S3}
==========

Primary cutaneous aspergillosis in renal transplant patients is extremely rare^[@R5]^ as compared to pulmonary aspergillosis. It occurs due to the immunocompromised state, and usually involves sites of skin injury, such as intravenous catheter sites, sites of traumatic inoculation, under adhesive dressings, burns or surgical wounds.^[@R5],[@R6]^ In a study by Grossi *et al.*,^[@R7]^ *Aspergillus niger* infection accounted for 3.8% of all invasive fungal infections in thoracic organ transplant recipients. In a review of reports of cutaneous aspergillosis, van Burick^[@R6]^ found that *Aspergillus niger* species was causative in 6% of cases involving non-HIV-infected populations. Thomas *et al.*^[@R8]^ claim to report the first case of primary cutaneous aspergillosis caused by *Aspergillus niger,* in a surgical wound in a renal transplant recipient. In the present case, *Aspergillus niger* colonisation occurred in a long-standing pressure sore which developed post-transplant, most likely to have been caused by the patient\'s footwear. Primary cutaneous aspergillosis in solid-organ transplant recipients generally occurs in the setting of a normal neutrophil count,^[@R6]^ as in the present case. In all these patients, efforts should be made to search for evidence of spread to an extracutaneous site, such as the lung. Our patient had no evidence of extracutaneous aspergillosis.

Organ transplant recipients are at a high risk for development of *Mycobacterium tuberculosis* infection. The prevalence of tuberculosis in these patients, in various studies, has ranged from 0.26--10%, being higher in developing countries.^[@R1],[@R9]--[@R12]^ The mean duration of time between transplantation and the occurrence of tuberculosis in various reports has ranged from 1 to 21 months.^[@R1],[@R10]--[@R12]^ *Mycobacterium tuberculosis* infection in renal transplant recipients usually occurs due to reactivation of latent tuberculous lesions.^[@R1]^ Our patient had not undergone testing for latent tuberculous infection prior to transplantation. There is a high rate of extrapulmonary tuberculosis in renal transplant recipients.^[@R1],[@R11]^ The symptoms of infection are often attenuated or atypical, leading to delayed diagnosis. Hence, many of these patients already have disseminated tuberculosis at the time of presentation. Due to the high frequency of anergy in immunosuppressed patients, a false-negative result is often obtained with the Mantoux test, further adding to the difficulty in diagnosis.

The present case emphasizes that opportunistic infections are an important cause of morbidity and mortality among renal transplant recipients. The use of newer immunosuppressive agents such as tacrolimus and mycophenolate mofetyl, antirejection therapy with steroids, the general state of malnutrition in transplant recipients, the endemic nature of certain infections, lack of proper hygiene, and lack of protective measures against infection, particularly in the hospital environment are factors contributing to the high incidence of opportunistic infections in renal transplant recipients.^[@R1]^ Regular monitoring of the level of immunosuppression is critical. Early suspicion and an aggressive diagnostic approach are important for timely diagnosis and treatment of these infections. However, there are unfortunate situations, as in the present case, where the clinician has to deal with multiple complications, and it becomes very difficult to strike a balance between immunosuppression and control of infection. The use of prophylactic antimicrobial agents and vaccinations may be helpful in certain cases.^[@R1]^
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